Search hospitals
>
Illinois
>
Springfield
Springfield Clinic
Claim this profile
Springfield, Illinois 62702
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
352 reported clinical trials
3 medical researchers
Summary
Springfield Clinic is a medical facility located in Springfield, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Springfield Clinic is involved with conducting 352 clinical trials across 485 conditions. There are 3 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, and Kevin Hazzard.
Area of expertise
Lung Cancer
Springfield Clinic has run 60 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Springfield Clinic has run 51 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Bryan A. Faller
Crossroads Cancer Center
7 years of reported clinical research
James L. Wade
Decatur Memorial Hospital
4 years of reported clinical research
Kevin Hazzard
Springfield Clinic
4 years of reported clinical research
Clinical Trials running at Springfield Clinic
Lung Cancer
Breast Cancer
Breast cancer
Prostate Cancer
Bladder Cancer
Cancer
Pancreatic Cancer
Multiple Myeloma
Esophageal cancer
Kidney Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting
2 awards
Phase 3
4 criteria
Ceralasertib + Durvalumab
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.
Recruiting
2 awards
Phase 3
10 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Springfield Clinic?
Springfield Clinic is a medical facility located in Springfield, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Springfield Clinic is involved with conducting 352 clinical trials across 485 conditions. There are 3 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, and Kevin Hazzard.
Where is Springfield Clinic located?
**Springfield Clinic Locations:** - **1st - 800 Building:** Located at 800 N 1st St, Springfield, IL. Services include radiology, lab, and physical therapy. Patient drop-off is available at the main entrance. - **Main Campus West:** Situated at 1025 S. 6th St, Springfield, IL. Offers radiology, lab services, and specialty care. Ample parking is available in the patient lot.
Who should I call to ask about financial aid or insurance network?
For financial assistance, insurance inquiries, or help with billing and payment plans at Springfield Clinic, contact the Patient Advocate Center at 217.391.7086, available Monday-Thursday 8 a.m.- 7 p.m., Friday 8 a.m.-5 p.m., and Saturday 8 a.m.- 12 p.m. For specific questions about in-network insurance plans, visit the Springfield Clinic website. For general inquiries, reach out at 217.528.7541 or use the online feedback form.
What insurance does Springfield Clinic accept?
Springfield Clinic Insurance Plans: - Aetna HMO & PPO & ACA/Exchange Plans - Blue Cross / Blue Shield PPO (In-network as of 1/1/24) - CIGNA HMO & PPO - Consociate Care PPO - Molina Dual Options Medicare-Medicaid Plan - YouthCare - Tricare (Non-network providers) - VA/Optum VACCN - VA Choice/Patient-Centered Community Care Programs - Medicare and Medicare Advantage plans from Aetna, Cigna, Health Alliance, Humana, Medical Associates Health Plan, and UnitedHealthcare. Springfield Clinic has a new five-year agreement with Blue Cross Blue Shield of Illinois, effective January 1, 2024, covering most BCBS plans except Blue Choice.
What awards or recognition has Springfield Clinic received?
Springfield Clinic, located in Springfield, Illinois, is celebrated as a Most Loved Workplace® by Newsweek and Best Practice Institute, underscoring its exceptional work environment and high employee satisfaction. The clinic's laboratory is nationally recognized for its excellence by CAP and COLA programs, affirming its dedication to providing top-quality lab services.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.